Conditions: Alzheimer's Disease Mild Cognitive Impairment
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 48
Healthy volunteers: yes

Brief summary:
Evaluate florbetapir (18F) positron emission tomography (PET) imaging for distinguishing Japanese healthy control subjects, from Japanese subjects with Alzheimer's disease (AD) or Mild cognitive impairment (MCI).

Detailed description:

Arms:
arm 1: None arm 2: MCI (mild cognitive impairment) arm 3: None

Interventions: intervention 1: florbetapir (18F)
Intervention descriptions: intervention 1: IV injection, 370 MBq(10mCi), single dose

Protocol document: